All Stories

  1. Genetic mechanisms of critical illness in Covid-19
  2. The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises
  3. Response
  4. In pursuit of the unicorn
  5. Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness
  6. COVID-19: UK frontline intensivists' emerging learning
  7. Reply to letter ‘Ultrasound-guided infraclavicular cannulation of the subclavian vein – still an ongoing misconception’
  8. Thirst-guided participant-controlled intravenous fluid rehydration: a single blind, randomised crossover study
  9. Low serum 25-hydroxyvitamin D status in the pathogenesis of stress fractures in military personnel: An evidenced link to support injury risk management
  10. Application of the optimized carbon monoxide rebreathing method for the measurement of total haemoglobin mass in chronic liver disease
  11. Cannulation of the subclavian vein using real-time ultrasound guidance
  12. The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate
  13. Matters of life and death: Change beyond planetary homeostasis
  14. A clinically applicable approach to continuous prediction of future acute kidney injury
  15. Evaluation of a digitally-enabled care pathway for acute kidney injury management in hospital emergency admissions
  16. Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial
  17. Implementation of a Digitally Enabled Care Pathway (Part 2): Qualitative Analysis of Experiences of Health Care Professionals
  18. Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care Costs
  19. A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications
  20. Diarrhoea in critical care is rarely infective in origin, associated with increased length of stay and higher mortality
  21. Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp
  22. Palaeoecological and genetic evidence for Neanderthal power locomotion as an adaptation to a woodland environment
  23. The 2018 report of the Lancet Countdown on health and climate change: shaping the health of nations for centuries to come
  24. The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness
  25. Replicating measurements of total hemoglobin mass (tHb-mass) within a single day: precision of measurement; feasibility and safety of using oxygen to expedite carbon monoxide clearance
  26. Clinically applicable deep learning for diagnosis and referral in retinal disease
  27. Metabolic phenotype of skeletal muscle in early critical illness
  28. Metabolic adjustment to high-altitude hypoxia: from genetic signals to physiological implications
  29. Letter in response to Google DeepMind and healthcare in an age of algorithms
  30. Eye care in the intensive care unit
  31. A practical guide to medical ethics for intensivists
  32. A practical guide to medical ethics for intensivists: Part 2
  33. The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health
  34. Could patient-controlled thirst-driven fluid administration lead to more rapid rehydration than clinician-directed fluid management? An early feasibility study
  35. The sensitivity of the human thirst response to changes in plasma osmolality: a systematic review
  36. Non-freezing cold injury: a multi-faceted syndrome
  37. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting – study protocol for a randomised feasibility trial for ...
  38. Critical care at the end of life: balancing technology with compassion and agreeing when to stop
  39. Reducing sound and light exposure to improve sleep on the adult intensive care unit: An inclusive narrative review
  40. Tropical cyclones and public health: how climate change is driving increasingly extreme weather—an essay by Fintan Hughes, Jack Hodkinson, and Hugh Montgomery
  41. Does hypoxia play a role in the development of sarcopenia in humans? Mechanistic insights from the Caudwell Xtreme Everest Expedition
  42. The future of UK healthcare: problems and potential solutions to a system in crisis
  43. Service evaluation of the implementation of a digitally-enabled care pathway for the recognition and management of acute kidney injury
  44. Humanizing critical care
  45. Hemoglobin concentration, total hemoglobin mass and plasma volume in patients: implications for anemia
  46. Cardiovascular assessment for non-cardiac surgery: European guidelines
  47. Christiana Figueres joins The Lancet Countdown—delivering on the promise of Paris
  48. Metabolic basis to Sherpa altitude adaptation
  49. Late Anthracycline-Related Cardiotoxicity in Low-Risk Breast Cancer Patients
  50. Total haemoglobin mass, but not haemoglobin concentration, is associated with preoperative cardiopulmonary exercise testing-derived oxygen-consumption variables
  51. Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning
  52. ACE and response to pulmonary rehabilitation in COPD: two observational studies
  53. Preventing the progression of climate change: one drug or polypill?
  54. The Lancet Countdown: tracking progress on health and climate change
  55. Predictors of total morbidity burden on days 3, 5 and 8 after cardiac surgery
  56. Pre-operative anaemia is associated with total morbidity burden on days 3 and 5 after cardiac surgery: a cohort study
  57. Genetic structure in the Sherpa and neighboring Nepalese populations
  58. Rectus Femoris Cross-Sectional Area and Muscle Layer Thickness: Comparative Markers of Muscle Wasting and Weakness
  59. Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
  60. ESICM LIVES 2016: part three
  61. Applying machine learning to automated segmentation of head and neck tumour volumes and organs at risk on radiotherapy planning CT and MRI scans
  62. Automated analysis of retinal imaging using machine learning techniques for computer vision
  63. Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies
  64. Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in COPD
  65. An Exploratory Study of Long-Term Outcome Measures in Critical Illness Survivors
  66. Diarrhoea in the critically ill is common, associated with poor outcome and rarely due to Clostridium difficile
  67. The Great British Medalists Project: A Review of Current Knowledge on the Development of the World’s Best Sporting Talent
  68. A comparison of the quality of image acquisition between the incident dark field and sidestream dark field video-microscopes
  69. Caudwell Xtreme Everest: An Overview
  70. Genetic determinants of survival
  71. Genetic determinants of survival
  72. Athlome Project Consortium: a concerted effort to discover genomic and other “omic” markers of athletic performance
  73. Health and climate change: policy responses to protect public health
  74. Improving outcomes in patients with Acute Kidney Injury: the impact of hospital based automated AKI alerts
  75. Fasciitis frequently accompanies myopathy in acute critical illness muscle wasting: Evidence from qualitative ultrasound and muscle biopsy analysis
  76. Three years of Extreme Physiology & Medicine
  77. Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies
  78. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting
  79. Postoperative morbidity after surgical aortic valve replacement or transcatheter valve implantation: a prospective cohort study
  80. SP238AKI ALERTS: USING ADDITION OF SERUM BICARBONATE TO PREDICT OUTCOMES
  81. A pilot study of change in fracture risk in patients with acute respiratory distress syndrome
  82. Design and conduct of Xtreme Everest 2: An observational cohort study of Sherpa and lowlander responses to graduated hypobaric hypoxia
  83. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
  84. The Relationship Between Lower Limb Bone and Muscle in Military Recruits, Response to Physical Training and Influence of Smoking Status
  85. Genetic Factors Associated with Exercise Performance in Atmospheric Hypoxia
  86. The Effect of Renin Angiotensin System Genetic Variants in Acute Pancreatitis
  87. Oral Coenzyme Q10 Supplementation Does Not Prevent Cardiac Alterations During a High Altitude Trek to Everest Base Camp
  88. S141 Tumour Necrosis Factor Receptor 1 Shedding Is Related To Acute Skeletal Muscle Wasting In Critical Illness
  89. Trial of the Route of Early Nutritional Support in Critically Ill Adults
  90. A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD
  91. Pupil Dynamics in Hypoxic Conditions: Caudwell Xtreme Everest Results
  92. Reply to 'A note of caution about the excess winter deaths measure'
  93. How wasting is saving: Weight loss at altitude might result from an evolutionary adaptation
  94. Genome-Scale Methods Converge on Key Mitochondrial Genes for the Survival of Human Cardiomyocytes in Hypoxia
  95. Effects of Prolonged Exposure to Hypobaric Hypoxia on Oxidative Stress, Inflammation and Gluco-Insular Regulation: The Not-So-Sweet Price for Good Regulation
  96. Use of interferon beta for acute respiratory distress syndrome: proceed with caution – Authors' reply
  97. Climate change and human survival
  98. Climate warming will not decrease winter mortality
  99. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study
  100. Children must be protected from the tobacco industry's marketing tactics
  101. S134 Activity monitoring in intensive care unit survivors: Assessing daily physical activity with objective outcome measures
  102. S54 Preservation of mitochondrial oxidative capacity in critically ill patients balances reduction in mitochondrial biogenesis
  103. Acute Skeletal Muscle Wasting in Critical Illness
  104. Climate change: the challenge for healthcare professionals
  105. Response to Letter About Article, "Left Ventricular Wall Thickness and the Presence of Asymmetric Hypertrophy in Healthy Young Army Recruits: Data From the LARGE Heart Study"
  106. The Use of Skeletal Muscle Near Infrared Spectroscopy and a Vascular Occlusion Test at High Altitude
  107. No evidence for a local renin-angiotensin system in liver mitochondria
  108. Surviving in a crevasse
  109. Genetic Signatures Reveal High-Altitude Adaptation in a Set of Ethiopian Populations
  110. Association Analysis of ACE and ACTN3 in Elite Caucasian and East Asian Swimmers
  111. Cerebral venous system and anatomical predisposition to high-altitude headache
  112. Tobacco industry lobbyists and their health-care clients
  113. Left Ventricular Wall Thickness and the Presence of Asymmetric Hypertrophy in Healthy Young Army Recruits: Data From the LARGE Heart Study
  114. Bone structure and geometry in young men: The influence of smoking, alcohol intake and physical activity
  115. Association between preoperative haemoglobin concentration and cardiopulmonary exercise variables: a multicentre study
  116. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome
  117. CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
  118. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chr...
  119. Conference, conscience and climate
  120. T3 Acute Muscle Loss in the Critically Ill: From Bedside to Bench
  121. S48 The Effect of Angiotensin-Converting Enzyme Inhibition on Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: A Randomised Controlled Trial
  122. Cardiopulmonary exercise testing predicts postoperative outcome in patients undergoing gastric bypass surgery
  123. Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing
  124. Media reports fuelled by authors' claims
  125. Duration of preceding hypertension is associated with prolonged length of ICU stay
  126. Neuromuscular Blockade and Skeletal Muscle Weakness in Critically Ill Patients
  127. 018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity:...
  128. Closed and open breathing circuit function in healthy volunteers during exercise at Mount Everest base camp (5300 m)
  129. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery
  130. Variation in the uncoupling protein 2 and 3 genes and human performance
  131. Health risks, present and future, from global climate change
  132. The Lichfield bone study: the skeletal response to exercise in healthy young men
  133. Investigating diarrhoea on the ICU: a retrospective study
  134. Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men
  135. Extreme Physiology & Medicine: a new journal focussed on integrative human physiology under stress
  136. Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest
  137. P66 Inter-observer reliability of ultrasound to measure rectus femoris cross-sectional area in critically ill patients
  138. The role of nitrogen oxides in human adaptation to hypoxia
  139. Genetic Influences in Sport and Physical Performance
  140. Sudden exertional death in sickle cell trait: Figure 1
  141. Review article: pancreatic renin-angiotensin systems in health and disease
  142. Cerebral Artery Dilatation Maintains Cerebral Oxygenation at Extreme Altitude and in Acute Hypoxia—An Ultrasound and MRI Study
  143. Normobaric hypoxia impairs human cardiac energetics
  144. The ACE Gene and Human Performance
  145. Red blood cell storage is associated with length of stay and renal complications after cardiac surgery
  146. Climate change, ill health, and conflict
  147. Global health and climate change: moving from denial and catastrophic fatalism to positive action
  148. Association of a sequence variant in DAB2IP with coronary heart disease
  149. A novel ambulatory closed circuit breathing system for use during exercise
  150. Prolongation of the Corrected QT Complex - A Cause of Sudden Cardiac Death in the Mountain Environment?
  151. Tissue Oxygen Saturation and Outcome after Cardiac Surgery
  152. Neuromuscular Blockers and ARDS
  153. Structure to function: muscle failure in critically ill patients
  154. TheACEGene and Performance
  155. Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp
  156. Effect of acute hypoxia on QTc interval in respiratory patients undergoing fitness to fly tests
  157. Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia
  158. Arrhythmias
  159. Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlanders
  160. Caudwell Xtreme Everest Expedition
  161. W56 TELOMERES ARE SHORTER IN PATIENTS WITH POLYGENIC AND MONOGENIC FORMS OF CORONARY HEART DISEASE
  162. The Effect of High-Altitude on Human Skeletal Muscle Energetics: 31P-MRS Results from the Caudwell Xtreme Everest Expedition
  163. The anaesthetist and the environment
  164. Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors
  165. A Review of Electrocardiography in the High Altitude Environment
  166. Chapter 1. Introduction
  167. Chapter 2. Surge capacity and infrastructure considerations for mass critical care
  168. Chapter 3. Coordination and collaboration with interface units
  169. Chapter 4. Manpower
  170. Chapter 5. Essential equipment, pharmaceuticals and supplies
  171. Chapter 6. Protection of patients and staff during a pandemic
  172. Chapter 7. Critical care triage
  173. Chapter 8. Medical procedures
  174. Chapter 9. Educational process
  175. Variation in human performance in the hypoxic mountain environment
  176. C-Reactive Protein Gene Variant and the Human Left Ventricular Growth Response to Exercise: Data From the LARGE Heart Study
  177. Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study
  178. DOWN-REGULATION OF ACE EXPRESSION IN HUVECS USING siRNA RESULTS IN DOWN-REGULATION OF UCP2 EXPRESSION: A POTENTIAL MECHANISM OF THE CLINICAL BENEFIT OF ACE-INHIBITORS?
  179. Genetic research and testing in sport and exercise science: A review of the issues
  180. Climate change is not the biggest global health threat – Authors' reply
  181. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes
  182. Climate change: how grave the threat?
  183. Mountain mortality: a review of deaths that occur during recreational activities in the mountains
  184. Managing the health effects of climate change
  185. Higher IL-6 levels but not IL6 −174G>C or −572G>C genotype are associated with post-operative complication following coronary artery bypass graft (CABG) surgery
  186. Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest
  187. Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers
  188. Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study
  189. The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction
  190. Tissue oxygen saturation during anaesthesia and cardiac surgery, and its association with ICU outcome
  191. Poster Session Abstracts
  192. The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease
  193. The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m)
  194. Angiotensin-converting enzyme genotype may predict survival following major trauma
  195. Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure
  196. Genetophysiology: Using Genetic Strategies to Explore Hypoxic Adaptation
  197. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype
  198. Genetic Variation and Activity of the Renin-Angiotensin System and Severe Hypoglycemia in Type 1 Diabetes
  199. Level of Ex Vivo Interleukin 6 Expression in Human Peripheral Fat Compared with Other Tissues
  200. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease
  201. High Altitude Arrhythmias
  202. Changes in thenar eminence tissue oxygen saturation measured using near-infrared spectroscopy suggest ischaemic preconditioning in a repeated arterial occlusion forearm ischaemia model
  203. Tissue oxygen saturation during anaesthesia, cardiopulmonary bypass and intensive care stay for cardiac surgery
  204. The medical impacts of climate change
  205. Angiotensin-Converting Enzyme Genotype and Successful Ascent to Extreme High Altitude
  206. Genetic Basis of Physical Fitness
  207. The association of left ventricular mass with blood pressure, cigarette smoking and alcohol consumption; data from the LARGE heart study
  208. Impact of genetic factors on outcome from brain injury
  209. ROLE OF BACTERIAL ENDOTOXIN IN CHRONIC HEART FAILURE
  210. Genetic Risk Factors for Subarachnoid Hemorrhage
  211. Angiotensin-Converting Enzyme Genotype Interacts With Systolic Blood Pressure to Determine Coronary Heart Disease Risk in Healthy Middle-Aged Men
  212. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease
  213. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics
  214. Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant
  215. Caudwell Xtreme Everest: a field study of human adaptation to hypoxia
  216. Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training
  217. The Impact of ACE Genotype on Serum ACE Activity in a Black South African Male Population
  218. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart
  219. Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle
  220. The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms
  221. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease
  222. Glucose-Insulin and Potassium Infusions in Septic Shock
  223. PPARα gene variation and physical performance in Russian athletes
  224. Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth
  225. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents
  226. Assessment of hypoxia in children with cystic fibrosis
  227. Factors affecting a climber’s ability to ascend Mont Blanc
  228. Terrorism and the Medical Response
  229. Variation in the Interleukin-6 Gene Is Associated with Impaired Cognitive Development in Children Born Prematurely: A Preliminary Study
  230. No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans
  231. ACE Genotype Is Not Associated With Elite Endurance Athlete Status In Kenyans
  232. W13-P-023 Common haplotypes of the IL18 gene and their effect on cardiovascular disease progression following an inflammatory insult
  233. Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms
  234. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms
  235. Performance at altitude and angiotensin I-converting enzyme genotype
  236. Does Interleukin-6 Genotype Influence Cerebral Injury or Developmental Progress After Preterm Birth?
  237. 104 Does Common Variation In The Cylcooxygenase-2 Gene Affect Neuro-Cognitive Outcome after Premature Birth?
  238. Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene
  239. ACE Gene Polymorphism in COPD
  240. ACE Gene Polymorphism in COPD
  241. Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease
  242. IL-6?174G/C genotype is associated with the bone mineral density response to oestrogen replacement therapy in post-menopausal women
  243. Gene-environment interactions and the response to exercise
  244. The ACE gene insertion/deletion polymorphism and elite endurance swimming
  245. Cardiac effects of anabolic steroids
  246. The −344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men
  247. ?Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2
  248. The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype
  249. Bradykinin receptor gene variant and human physical performance
  250. Genetic Variation and Physical Performance
  251. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants
  252. The renin–angiotensin system and physical performance
  253. Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia
  254. Is Interleukin-6 -174 Genotype Associated With the Development of Septicemia in Preterm Infants?
  255. Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease
  256. Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension
  257. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
  258. Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension
  259. Stressing the system
  260. ACE in COPD: a therapeutic target?
  261. Renin–angiotensin systems: the new frontier
  262. In search of genetic precision
  263. In search of genetic precision
  264. Cortical bone resorption during exercise is interleukin-6 genotype-dependent
  265. No association between high-altitude tolerance and the ACE I/D gene polymorphism
  266. Left Ventricular Mass: Reliability of M-Mode and 2-Dimensional Echocardiographic Formulas
  267. Human Performance: A Role for the ACE Genotype?
  268. Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Is Associated with Susceptibility and Outcome in Acute Respiratory Distress Syndrome
  269. Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene and Arterial Oxygen Saturation at High Altitude
  270. The Gly389Arg beta-1 adrenoceptor polymorphism and cardiovascular disease: time for a rethink in the funding of genetic studies?
  271. Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease?
  272. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers
  273. Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism
  274. ACE Genotype and Performance
  275. Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk
  276. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release
  277. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers
  278. Peroxisome Proliferator-Activated Receptor alpha Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension
  279. The Effect of Fibrinogen Genotype on Fibrinogen Levels after Strenuous Physical Exercise
  280. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training
  281. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response
  282. The angiotensin converting enzyme I/D polymorphism in Russian athletes
  283. Effect of aCOL1A1Sp1 Binding Site Polymorphism on Arterial Pulse Wave Velocity
  284. Predictive genetics and predictive morphology have certain similarities
  285. Interleukin-6 Gene -174G>C and -572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery
  286. Statin therapy and the acute inflammatory response after coronary artery bypass grafting
  287. Angiotensin-Converting Enzyme and Genetics at High Altitude
  288. Angiotensin-I Converting Enzyme Genotype-Dependent Benefit from Hormone Replacement Therapy in Isometric Muscle Strength and Bone Mineral Density
  289. Increased QT dispersion with the D-allele of the ACE polymorphism
  290. Elite swimmers and the D allele of the ACE I/D polymorphism
  291. Left Ventricular Hypertrophy With Exercise and ACE Gene Insertion/Deletion Polymorphism : A Randomized Controlled Trial With Losartan
  292. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women
  293. Genetic Variation and the Response to Exercise
  294. Predisposing Genes, High-Risk Environments and Coronary Artery Disease: LPL and Fibrinogen as Examples
  295. The ACE I/D Polymorphism and Human Physical Performance
  296. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6
  297. Gene-environment interactions and the response to exercise
  298. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload
  299. Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats
  300. The genetics of physical fitness
  301. The genetics of critical illness
  302. Cardiac reserve: linking physiology and genetics
  303. The ACE gene and muscle performance
  304. Human angiotensin I-converting enzyme gene and endurance performance
  305. Reply from Dr Marko Kerac
  306. Exercise training enhances endothelial function in young men
  307. A Low-Cost Spacer Device
  308. High intensity training and the heart
  309. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training
  310. Gene-Environment Interaction in the Determination of Levels of Plasma Fibrinogen
  311. A Low Cost Spacer Device Used for Asthma Treatment in a Calcutta Street Clinic to Improve Efficacy of Metered Dose Inhalers
  312. Daily patterns of secretion of neurohypophysial hormones in man: effect of age
  313. Human gene for physical performance
  314. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27
  315. Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training
  316. Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered?
  317. Gene-environment interaction in the determination of plasma levels of fibrinogen
  318. 3,4-methylenedioxymethamphetamine (MDMA, or “ecstasy”) and associated hypoglycemia
  319. Gene-Environment Interaction in the Determination of Levels of Haemostatic Variables Involved in Thrombosis and Fibrinolysis
  320. 16. Gene-environment interaction in the determination of plasma fibrinogen levels
  321. The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G-453-A Polymorphism of the  -Fibrinogen Gene
  322. Gene-environment interaction in coronary artery disease (CAD)
  323. Drug points: Rhabdomyolysis and multiple system organ failure with streptokinase
  324. Pulmonary embolism as a cause of pulmonary oedema
  325. Heparin in unstable angina
  326. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy
  327. Interpretation of electrocardiograms by doctors
  328. Salicylate intoxication causing a severe systemic inflammatory response and rhabdomyolysis
  329. Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
  330. Magnesium and myocardial infarction
  331. Thrombolytic Therapy for Myocardial Infarction
  332. Cerebral mass lesions in patients with AIDS.
  333. Letter to the editor